Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-003766
Filing Date
2017-01-17
Accepted
2017-01-17 07:28:35
Documents
2
Period of Report
2017-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5351
2 POA DOCUMENT poa.txt EX-24.3_694927 3268
  Complete submission text file 0001209191-17-003766.txt   9984
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Issuer) CIK: 0001533040 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 257 SIMARANO DRIVE, SUITE 101 MARLBOROUGH MA 01752
Business Address
Eliseev Alexey (Reporting) CIK: 0001694380 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36304 | Film No.: 17529191